{"id":"https://openalex.org/W4415898989","doi":"https://doi.org/10.1136/jitc-2025-sitc2025.0418","title":"418 Novel PD-1xKIR3DL3 bispecific antibodies take the brakes off T and NK cells","display_name":"418 Novel PD-1xKIR3DL3 bispecific antibodies take the brakes off T and NK cells","publication_year":2025,"publication_date":"2025-11-01","ids":{"openalex":"https://openalex.org/W4415898989","doi":"https://doi.org/10.1136/jitc-2025-sitc2025.0418"},"language":"en","primary_location":{"id":"doi:10.1136/jitc-2025-sitc2025.0418","doi":"https://doi.org/10.1136/jitc-2025-sitc2025.0418","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2025-sitc2025.0418","pdf_url":"https://jitc.bmj.com/content/13/Suppl_2/A474.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular and Young Investigator Award Abstracts","raw_type":"proceedings-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://jitc.bmj.com/content/13/Suppl_2/A474.full.pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5024296684","display_name":"Devin T. Corrigan","orcid":"https://orcid.org/0000-0002-8449-8277","observed_orcids":["https://orcid.org/0000-0002-8449-8277"]},"institutions":[{"id":"https://openalex.org/I129975664","display_name":"Albert Einstein College of Medicine","ror":"https://ror.org/05cf8a891","country_code":"US","type":"education","lineage":["https://openalex.org/I129975664","https://openalex.org/I4210112371"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Devin Corrigan","raw_affiliation_strings":["Albert Einstein College of Medicine, Bronx, NY, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Albert Einstein College of Medicine, Bronx, NY, USA","institution_ids":["https://openalex.org/I129975664"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100927530","display_name":"Xiaona Sun","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I129975664","display_name":"Albert Einstein College of Medicine","ror":"https://ror.org/05cf8a891","country_code":"US","type":"education","lineage":["https://openalex.org/I129975664","https://openalex.org/I4210112371"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Xiaona Sun","raw_affiliation_strings":["Albert Einstein College of Medicine, Bronx, NY, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Albert Einstein College of Medicine, Bronx, NY, USA","institution_ids":["https://openalex.org/I129975664"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001963621","display_name":"Bijan A. Etemad-Gilbertson","orcid":"https://orcid.org/0000-0002-7318-8441","observed_orcids":["https://orcid.org/0000-0002-7318-8441"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Bijan Etemad-Gilbertson","raw_affiliation_strings":["NextPoint Therapeutics, Cambridge, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"NextPoint Therapeutics, Cambridge, MA, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103235600","display_name":"Yao Wei","orcid":"https://orcid.org/0000-0001-9329-0278","observed_orcids":["https://orcid.org/0000-0001-9329-0278"]},"institutions":[{"id":"https://openalex.org/I129975664","display_name":"Albert Einstein College of Medicine","ror":"https://ror.org/05cf8a891","country_code":"US","type":"education","lineage":["https://openalex.org/I129975664","https://openalex.org/I4210112371"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Yao Wei","raw_affiliation_strings":["Albert Einstein College of Medicine, Bronx, NY, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Albert Einstein College of Medicine, Bronx, NY, USA","institution_ids":["https://openalex.org/I129975664"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044042999","display_name":"Xiaoxin Ren","orcid":"https://orcid.org/0000-0002-2371-3658","observed_orcids":["https://orcid.org/0000-0002-2371-3658"]},"institutions":[{"id":"https://openalex.org/I129975664","display_name":"Albert Einstein College of Medicine","ror":"https://ror.org/05cf8a891","country_code":"US","type":"education","lineage":["https://openalex.org/I129975664","https://openalex.org/I4210112371"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Xiaoxin Ren","raw_affiliation_strings":["Albert Einstein College of Medicine, Bronx, NY, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Albert Einstein College of Medicine, Bronx, NY, USA","institution_ids":["https://openalex.org/I129975664"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5072231950","display_name":"Xingxing Zang","orcid":"https://orcid.org/0000-0001-5380-1942","observed_orcids":["https://orcid.org/0000-0001-5380-1942"]},"institutions":[{"id":"https://openalex.org/I129975664","display_name":"Albert Einstein College of Medicine","ror":"https://ror.org/05cf8a891","country_code":"US","type":"education","lineage":["https://openalex.org/I129975664","https://openalex.org/I4210112371"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Xingxing Zang","raw_affiliation_strings":["Albert Einstein College of Medicine, Bronx, NY, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Albert Einstein College of Medicine, Bronx, NY, USA","institution_ids":["https://openalex.org/I129975664"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":2490,"currency":"USD","value_usd":2490},"apc_paid":{"value":2490,"currency":"USD","value_usd":2490},"fwci":null,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":"A474","last_page":"A474"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9169999957084656,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9169999957084656,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11020","display_name":"Immune Cell Function and Interaction","score":0.04529999941587448,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.033399999141693115,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/bispecific-antibodies","display_name":"bispecific antibodies","score":0.8569999933242798},{"id":"https://openalex.org/keywords/pd-1","display_name":"PD-1","score":0.8199999928474426},{"id":"https://openalex.org/keywords/kir3dl3","display_name":"KIR3DL3","score":0.9990000128746033},{"id":"https://openalex.org/keywords/immune-checkpoint-blockade","display_name":"immune checkpoint blockade","score":0.8939999938011169},{"id":"https://openalex.org/keywords/natural-killer-cells","display_name":"natural killer cells","score":0.8730000257492065},{"id":"https://openalex.org/keywords/t-cells","display_name":"T cells","score":0.9139999747276306},{"id":"https://openalex.org/keywords/tumor-cell-lysis","display_name":"tumor cell lysis","score":0.6019999980926514},{"id":"https://openalex.org/keywords/antibody-conformation","display_name":"antibody conformation","score":0.5809999704360962},{"id":"https://openalex.org/keywords/single-chain-variable-fragment","display_name":"scFv","score":0.6100000143051147},{"id":"https://openalex.org/keywords/antitumor-immunity","display_name":"antitumor immunity","score":0.6380000114440918},{"id":"https://openalex.org/keywords/solid-tumors","display_name":"solid tumors","score":0.48899999260902405},{"id":"https://openalex.org/keywords/pembrolizumab","display_name":"pembrolizumab","score":0.6629999876022339},{"id":"https://openalex.org/keywords/nivolumab","display_name":"nivolumab","score":0.9869999885559082},{"id":"https://openalex.org/keywords/nfat-activation","display_name":"NFAT activation","score":0.5590000152587891},{"id":"https://openalex.org/keywords/immunological-synapse","display_name":"immunological synapse","score":0.796999990940094},{"id":"https://openalex.org/keywords/tumor-cell-internalization","display_name":"tumor cell internalization","score":0.41499999165534973}],"concepts":[{"id":"https://openalex.org/C3020495827","wikidata":"https://www.wikidata.org/wiki/Q426141","display_name":"Bispecific antibody","level":4,"score":0.7634999752044678},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.47690001130104065},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.4562999904155731},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.4043000042438507},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.2987000048160553},{"id":"https://openalex.org/C3018913218","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody response","level":3,"score":0.29179999232292175},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.27570000290870667},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.26829999685287476},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.2651999890804291},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.25999999046325684},{"id":"https://openalex.org/C2908856526","wikidata":"https://www.wikidata.org/wiki/Q16252627","display_name":"Antibody therapy","level":4,"score":0.25679999589920044},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.251800000667572}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1136/jitc-2025-sitc2025.0418","doi":"https://doi.org/10.1136/jitc-2025-sitc2025.0418","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2025-sitc2025.0418","pdf_url":"https://jitc.bmj.com/content/13/Suppl_2/A474.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular and Young Investigator Award Abstracts","raw_type":"proceedings-article"}],"best_oa_location":{"id":"doi:10.1136/jitc-2025-sitc2025.0418","doi":"https://doi.org/10.1136/jitc-2025-sitc2025.0418","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2025-sitc2025.0418","pdf_url":"https://jitc.bmj.com/content/13/Suppl_2/A474.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular and Young Investigator Award Abstracts","raw_type":"proceedings-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9763000011444092}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4415898989.pdf","grobid_xml":"https://content.openalex.org/works/W4415898989.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4380886506","https://openalex.org/W3177496545","https://openalex.org/W4409092410","https://openalex.org/W3212518782","https://openalex.org/W4362532159","https://openalex.org/W2796854280","https://openalex.org/W4409631835","https://openalex.org/W4200506442","https://openalex.org/W4310236384","https://openalex.org/W3204952209"],"abstract_inverted_index":{"Background":[0],"PD-1":[1,19,98,210,260,300,350,359],"blockade":[2,20,64],"therapy":[3],"revolutionized":[4],"treatment":[5],"of":[6,45,89,107,207,240,250,272,278,369,374],"solid":[7,50],"tumors,":[8,51],"but":[9,263,361],"response":[10],"and":[11,52,60,69,97,124,128,142,150,176,192,209,216,234,237,245,281,301,324,335,378],"eligibility":[12],"rates":[13],"remain":[14],"low.":[15],"Bispecific":[16],"antibodies":[17,91],"combining":[18],"with":[21,182,371],"other":[22,311],"immune":[23,41,375],"checkpoint":[24,42],"inhibitors,":[25],"such":[26],"as":[27,194],"PD-1xCTLA-4,":[28],"present":[29],"a":[30,39,87,349],"promising":[31],"strategy":[32],"to":[33,99,116,178,211,228,248,291,298,321,353,357],"augment":[34],"monotherapies.":[35],"We":[36,307,365],"previously":[37],"identified":[38],"novel":[40,285],"pathway":[43],"comprised":[44],"HHLA2":[46],"(B7-H7),":[47],"expressed":[48,57],"on":[49,58,155,231],"its":[53,354],"inhibitory":[54],"receptor":[55,143],"KIR3DL3,":[56],"T":[59],"NK":[61,233],"cells.":[62],"KIR3DL3":[63,82,96,127,208,230,265,302],"showed":[65],"increased":[66],"anti-tumor":[67,382],"effects":[68],"is":[70],"currently":[71],"being":[72,186],"evaluated":[73],"in":[74,113,134,187,214,332,379],"phase":[75],"I":[76],"clinical":[77],"trials.":[78],"To":[79],"supplement":[80],"our":[81],"blocking":[83,125,144,177,303],"antibody,":[84],"we":[85,288],"generated":[86,112],"panel":[88,106],"bispecific":[90,286],"(bsAbs)":[92],"that":[93,249,277],"block":[94,205,229],"both":[95,126,179,203,333],"further":[100,165,222,346],"improve":[101],"upon":[102],"each":[103],"monotherapy.Methods":[104],"A":[105],"fully":[108],"human":[109],"bsAbs":[110,131],"were":[111,132],"three":[114,169,305,340],"conformations":[115],"determine":[117,292],"the":[118,168,183,188,195,199,226,251,317,327,339],"best":[119],"structure":[120],"for":[121,163,221,274,345,381],"maintaining":[122],"binding":[123,136,175,206,314,323,329],"PD-1.":[129],"KIR3DL3xPD-1":[130],"tested":[133,170],"various":[135],"assays":[137,145,373],"(biolayer":[138],"interferometry,":[139],"on-cell":[140],"binding)":[141],"(immune":[146],"synapse,":[147],"NFAT":[148],"activation,":[149,377],"tumor":[151],"cell":[152,376],"lysis).":[153],"Based":[154],"these":[156],"results,":[157],"one":[158,342],"candidate":[159],"bsAb":[160,171,294],"was":[161,219,257,296,343],"selected":[162,220],"ongoing":[164],"characterization.Results":[166],"Of":[167,198,338],"conformations,":[172],"two":[173,200],"maintained":[174],"target":[180,242],"receptors":[181],"anti-PD-1":[184,313],"arms":[185,315,330],"native":[189,318,334],"IgG":[190,319],"conformation":[191],"anti-KIR3DL3":[193,253,328],"scFv":[196,336],"arms.":[197],"remaining":[201],"bsAbs,":[202],"could":[204],"their":[212],"ligands":[213],"vitro":[215],"one,":[217],"PK-E1,":[218,348],"characterization.":[223],"PK-E1":[224,256,275,370],"retained":[225],"ability":[227],"primary":[232],"NK92":[235],"cells":[236,243,262],"increase":[238],"lysis":[239],"HHLA2+":[241],"HCC827":[244],"K562,":[246],"identical":[247],"parental":[252],"mAb.":[254],"Additionally,":[255],"internalized":[258],"by":[259],"expressing":[261,266],"not":[264],"cells,":[267],"indicating":[268],"an":[269],"additional":[270,372],"mechanism":[271],"action":[273],"like":[276,310],"pembrolizumab":[279],"(Keytruda)":[280],"nivolumab":[282],"(Opdivo).Conclusions":[283],"As":[284],"constructs,":[287],"set":[289],"out":[290],"which":[293],"design":[295],"optimal":[297],"maintain":[299],"among":[304],"constructs.":[306],"found":[308],"that,":[309],"reports,":[312],"required":[316],"orientation":[320],"retain":[322],"blocking,":[325],"while":[326],"functioned":[331],"formats.":[337],"constructs":[341],"chosen":[344],"characterization,":[347],"IgG4(H)-scFv(KIR3DL3)":[351],"due":[352],"similar":[355],"performance":[356],"PK-E3,":[358],"IgG4(L)-scFv(KIR3DL3),":[360],"more":[362],"robust":[363],"expression.":[364],"are":[366],"continuing":[367],"characterization":[368],"vivo":[380],"effects.":[383]},"counts_by_year":[],"updated_date":"2026-11-02T09:45:03.842371","created_date":"2025-11-05T00:00:00"}